卫生组织进行了新的结核病测试,目的是促进全球对这一疾病的早期诊断和治疗。 WHO prequalifies new TB test, aiming to boost early diagnosis and treatment of the disease worldwide.

世界卫生组织(世卫组织)对Xpert MTB/RIF Ultra进行了资格预审,这是符合其严格标准的第一次结核病诊断测试。 The World Health Organization (WHO) has prequalified the Xpert® MTB/RIF Ultra, the first TB diagnostic test meeting their strict standards. 这项测试在截肢样本中检测到Mycobactium结核病的遗传物质,并在数小时内查明抗药性菌株,目的是改进对结核病的早期诊断和治疗,结核病是每年造成100多万人死亡的一种疾病。 This test, which detects the genetic material of Mycobacterium tuberculosis in sputum samples and identifies drug-resistant strains within hours, aims to improve early diagnosis and treatment of tuberculosis, a disease responsible for over a million deaths annually. 世卫组织的资格预审确保测试的质量、安全和绩效,有助于扩大全球获得高质量结核病诊断的机会。 The WHO's prequalification ensures the test's quality, safety, and performance, helping to expand access to high-quality TB diagnostics globally.